Request for Covid-19 Impact Assessment of this Report
Market Dynamics
The growth driver of this market is mostly due to the factors related to unwanted pregnancies and pregnancy complications. A number of women also account menstrual related pain and suffering as reasons for the use of contraceptives drugs and devices. Awareness related to safe sexual intimacy and control of population are also drivers of growth of this market.
There are various sceptical thoughts related to the use of such drugs and devices. Many fear of the side effects and issues like infertility. Religion and cultural barriers are also restraints in this market. In some countries, there is limited availability of contraceptives which leads to less accessibility in different markets.
Market Segmentation
The market is segmented broadly into two categories i.e. drugs and devices. Further segregation can be done on the basis of their application. Contraceptive drugs have three different forms of application, they are pills, patches and injectable. The contraceptive devices are divided into male and female devices. Segmentation can also be done on the basis of mode of delivery, type of device, gender specific and geography based.
Regional/Geographic Analysis
The segments based on regions or geography are North America, Asia-Pacific, Europe and Rest of world. North America dominates this market with the highest demand. Europe comes second after North America in terms of global market share. The developing nations have shown a rise in demand of such drugs and devices making them potential markets for the future.
Key Players
List of the major players in this market include Bayer Healthcare, Pfizer, Reckitt Benckiser, Lupin Pharmaceuticals, Johnson & Johnson and others.
The report contains comprehensive analysis on:
--> Contraceptives Drugs and Devices Market Segments
--> Contraceptives Drugs and Devices Market Drivers, Restraints and Opportunities
--> Contraceptives Drugs and Devices Market Size & Forecast 2016 to 2022
--> Supply & Demand Value Chain
--> Contraceptives Drugs and Devices Market Current Trends
--> Competition &Major Companies
--> Technology and R&D Status
--> Porters Five Force Analysis
--> Strategic and Critical Success Factor Analysis of Key Players
Regional analysis for Contraceptives Drugs and Devices Market includes
--> North America
>> US and Canada
--> Latin America
>> Mexico, Brazil, Argentina and Rest of Latin America
--> Western Europe
>> EU5 (Germany, France, Italy, Spain, U.K.)
>> Nordic Countries (Denmark, Finland, Norway, and Sweden)
>> Benelux (Belgium, The Netherlands, and Luxembourg)
>> Rest of Western Europe
--> Eastern Europe
>> Russia
>> Poland
>> Rest of Eastern Europe
--> Asia Pacific
>> China
>> India
>> Japan
>> Australia and New Zealand
>> Rest of Asia Pacific
--> Middle East and Africa
>> GCC countries (Saudi Arabia, Oman, Qatar, Bahrain, UAE and Kuwait)
>> South Africa
>> North Africa
>> Rest of Middle East and Africa
This report is an elaborate aggregation of primary inputs from industry experts and participants across the supply chain. It provides in-depth market segmentation that is derived from extensive product mapping exercises, macro-economic factors and other qualitative and quantitative insights. The impact of all such factors are delivered across multiple market segments and geographies.
Report Highlights::
--> Detailed Historical Overview (Market Origins, Product Launch Timeline, etc.)
--> Consumer and Pricing Analysis
--> Market dynamics of the industry
--> In-depth Market Segmentation
--> Historical and Projected Market Sizing in terms of volume and value
--> Recent market trends and Impact Factors
--> R&D Status and Technology Overview
--> Extensive Industry Structure Coverage
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...